Semaglutide May Reduce Craving in Alcohol Use Disorder
Phase 2 trial shows significant reduction in drinks per drinking day and weekly alcohol craving
Patients Hospitalized With COVID-19 Face Higher Long-Term Risk for Death, Rehospitalization
Multiorgan consequences of COVID-19 persist through 30 months after discharge
FDA Makes Access to Clozapine Easier for Patients With Schizophrenia
Patients will no longer have to provide blood test results before filling their prescription
2017 to 2022 Saw Rise in ED Orders for Buprenorphine for Opioid Use Disorder
One in nine patients starting with emergency prescription go on to receive continuous buprenorphine prescription within one year
Rates of ADHD Up in Adults With Autism, Intellectual Disability
Adults with autism and co-occurring ADHD have higher negative health outcome rates
Behavioral, Developmental Disorders in Children More Common in Recent Years
Caregivers with poorer mental health have higher odds of having children with behavioral issues
Machine Learning May Predict Progression to Serious Mental Illness
Performance better for transition to schizophrenia than for bipolar disorder
Melatonin Improves DNA Damage Repair Capacity in Night Shift Workers
Melatonin intervention linked to borderline significant increase in urinary 8-OH-dG, which is indicator of oxidative DNA damage repair capacity
Guidance Provided for Safe Use of Ketamine
Ketamine use outside of acute pain management and procedural sedation should be part of comprehensive treatment plan by trained medical professionals
Vitamin D Deficiency Tied to Depression Risk With Chronic Kidney Disease
Risk particularly heightened in men, but seen across kidney disease stages
